Junping Shi Selected Research

Alanine Transaminase (SGPT)

10/2023	Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis.
2/2023	Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study.
1/2023	Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials.
12/2020	Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria.
2/2018	Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.
4/2015	Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junping Shi Research Topics

Disease

27	Non-alcoholic Fatty Liver Disease 12/2023 - 06/2014
14	Inflammation (Inflammations) 01/2024 - 11/2015
14	Neoplasms (Cancer) 12/2021 - 01/2014
11	Fibrosis (Cirrhosis) 03/2023 - 01/2018
6	Chronic Hepatitis B 04/2024 - 04/2014
6	Fatty Liver 04/2024 - 11/2016
6	Alcoholic Fatty Liver 12/2023 - 11/2016
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 12/2016
4	Insulin Resistance 04/2023 - 01/2019
4	Body Weight (Weight, Body) 03/2023 - 10/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 10/2018
3	Metabolic Diseases (Metabolic Disease) 10/2023 - 01/2019
3	Adenocarcinoma of Lung 01/2021 - 01/2019
2	Autoimmune Hepatitis 01/2024 - 11/2020
2	Fatigue 01/2023 - 05/2021
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2023 - 10/2020
2	Cholangiocarcinoma 12/2021 - 09/2021
2	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2014
2	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2020
2	Hepatitis B 04/2021 - 02/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2020
2	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020 - 09/2019
1	Atherosclerosis 03/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Cognitive Dysfunction 01/2024
1	Pneumonia (Pneumonitis) 10/2023
1	Infections 10/2023
1	Necrosis 03/2023
1	Hypertension (High Blood Pressure) 02/2023
1	Venous Thromboembolism 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	COVID-19 01/2023

Drug/Important Bio-Agent (IBA)

6	Alanine Transaminase (SGPT)IBA 10/2023 - 04/2015
6	nasIBA 10/2023 - 06/2014
4	Antiviral Agents (Antivirals)IBA 04/2024 - 04/2015
4	EnzymesIBA 04/2023 - 12/2018
4	Hepatitis B e AntigensIBA 01/2023 - 04/2014
3	CholesterolIBA 12/2023 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
3	Leukocyte Elastase (Neutrophil Elastase)IBA 10/2019 - 11/2015
3	CytokinesIBA 01/2019 - 11/2015
2	Vitamin E FDA LinkGeneric 12/2023 - 03/2023
2	PrebioticsIBA 06/2023 - 12/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2023 - 01/2023
2	TransferasesIBA 03/2023 - 01/2023
2	Triglycerides (Triacylglycerol)IBA 03/2023 - 01/2023
2	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2023 - 01/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2023 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2019
2	CopperIBA 01/2023 - 10/2020
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2022
2	dapagliflozinIBA 01/2023 - 01/2022
2	AcidsIBA 01/2022 - 12/2019
2	olaparibIBA 09/2021 - 01/2020
2	Everolimus FDA Link 08/2021 - 01/2020
2	CrizotinibIBA 01/2021 - 11/2020
2	cabozantinibIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2020
2	HaptoglobinsIBA 01/2019 - 01/2018
2	Lipocalin-2IBA 01/2017 - 11/2016
1	AlkaloidsIBA 03/2024
1	Choline (Choline Chloride)IBA 03/2024
1	ApolipoproteinsIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	Insulin (Novolin)FDA Link 01/2024
1	Metformin (Glucophage)FDA LinkGeneric 01/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024
1	LinagliptinIBA 01/2024
1	AutoantigensIBA 01/2024
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2023
1	Betaine (C.B.B.)FDA Link 12/2023
1	Growth Hormone (Somatotropin)IBA 10/2023
1	Tenofovir (Viread)FDA Link 10/2023
1	entecavir FDA Link 10/2023
1	Protons (Proton)IBA 04/2023
1	HydrogenIBA 04/2023
1	Pioglitazone (Actos)FDA Link 03/2023
1	Keratin-18 (Keratin 18)IBA 02/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2023
1	Chelating AgentsIBA 01/2023
1	Sodium-Glucose Transport ProteinsIBA 01/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	Protein SIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	ZincIBA 01/2023
1	Vitamin K FDA Link 01/2023
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023
1	Copper Transport ProteinsIBA 01/2023
1	Liraglutide FDA Link 01/2023

Therapy/Procedure

18	Therapeutics 04/2024 - 01/2014
4	Drug Therapy (Chemotherapy) 03/2023 - 01/2020
3	Precision Medicine 01/2021 - 01/2019
1	Transplantation 06/2023
1	Fecal Microbiota Transplantation 06/2023